Lead Product(s) : Piperaquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : QIMR Berghofer Medical Research Institute | Clinical Network Services | Q-Pharm Pty Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 31, 2018
Lead Product(s) : Piperaquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : QIMR Berghofer Medical Research Institute | Clinical Network Services | Q-Pharm Pty Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Piperaquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Q-Pharm Pty Limited | Clinical Network Services | Sullivan Nicolaides Pathology | QIMR Berghofer Medical Research Institute | Army Malaria Institute, Australia
Deal Size : Inapplicable
Deal Type : Inapplicable
Experimental Falciparum Transmission to Anopheles
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
May 01, 2015
Lead Product(s) : Piperaquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Q-Pharm Pty Limited | Clinical Network Services | Sullivan Nicolaides Pathology | QIMR Berghofer Medical Research Institute | Army Malaria Institute, Australia
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Piperaquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Richmond Pharmacology
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
October 09, 2013
Lead Product(s) : Piperaquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Richmond Pharmacology
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Piperaquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Richmond Pharmacology
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
May 15, 2013
Lead Product(s) : Piperaquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Richmond Pharmacology
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
